HANNAH BAUMAN: Open Payments
NPI 1831841055 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,018 in 55 payments from 17 companies in 2025. Trend: 2023 $2,101 · 2024 $2,045 · 2025 $1,018
Food & beverage: $896Education: $123
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $160 |
| Regeneron Healthcare Solutions, Inc. | 5 | $149 |
| ABBVIE INC. | 15 | $141 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| Almirall LLC | 2 | $65 |
| UCB, Inc. | 3 | $62 |
| Incyte Corporation | 2 | $53 |
| LEO Pharma Inc. | 2 | $35 |
| Amgen Inc. | 2 | $29 |
Products named: Sotyktu, DUPIXENT, ILUMYA, RINVOQ, Klisyri, Bimzelx, OPZELURA, SKYRIZI.
Industry payments across KS — which companies pay providers there.
